The Egyptan International Company for Pharma Industries (EIPICO) will start production on its third plant in May, thelocal press reports. The factory, based in the Tenth of Ramadan City, cost EIPICO EGP 1 bn and is expected to contribute to the government’s fight against the covid-19 outbreak by producing genetically modified proteins.
More from Enterprise
Farmers aren’t borrowing to survive anymore — they’re investing
Medium-term loans rose more than 1k% to EGP 22.6 bn…
Global FDI rises in 2025, but recovery is skewed toward developed economies — and importantly, AI
Developed economies lead the upswing, while developing economies see modest…
NowPay lands in KSA with USD 20 mn JV with Tas’heel
KSA is witnessing “accelerating demand for modern payroll, HR, and…